{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:47:13Z","timestamp":1789710433008,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtho.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:11:24Z","timestamp":1718219484000},"page":"1438-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations"],"prefix":"10.1016","volume":"19","author":[{"given":"Kelsey","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Routbort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Fossella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo V.","family":"Negrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Altan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Pozadzides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinandos","family":"Skoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Cascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Ostrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-1185","authenticated-orcid":false,"given":"Xiuning","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2024.06.004_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw295","article-title":"Proportion of never-smoker non-small cell lung cancer patients at three diverse institutions","volume":"109","author":"Pelosof","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2024.06.004_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2017.06.031","article-title":"Increasing frequency of non-smoking lung cancer: presentation of patients with early disease to a tertiary institution in the UK","volume":"84","author":"Cufari","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2024.06.004_bib3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/JTO.0b013e318250ed9d","article-title":"Screening for germline EGFR T790M mutations through lung cancer genotyping","volume":"7","author":"Oxnard","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib4","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.cllc.2015.11.003","article-title":"Germline mutation of T790M and dual\/multiple EGFR mutations in patients with lung adenocarcinoma","volume":"17","author":"Lou","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2024.06.004_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13070","article-title":"Prevalence of germline findings among tumors from cancer types lacking hereditary testing guidelines","volume":"5","author":"Yap","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtho.2024.06.004_bib6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jtho.2017.08.011","article-title":"Germline mutations in DNA repair genes in lung adenocarcinoma","volume":"12","author":"Parry","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/JTO.0000000000000130","article-title":"Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations","volume":"9","author":"Gazdar","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.21037\/tlcr.2018.06.01","article-title":"Inherited lung cancer syndromes targeting never smokers","volume":"7","author":"Yamamoto","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2024.06.004_bib9","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.athoracsur.2007.10.012","article-title":"Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer","volume":"85","author":"Ikeda","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2024.06.004_bib10","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1200\/JCO.2010.31.4492","article-title":"Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation","volume":"29","author":"Ohtsuka","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib11","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1200\/JCO.2012.42.1586","article-title":"Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation","volume":"31","author":"van Noesel","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib12","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.01372","article-title":"Germline EGFR mutations and familial lung cancer","author":"Oxnard","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3892\/ol.2023.13868","article-title":"Germline EGFR mutations in lung cancer (Review)","volume":"26","author":"Liu","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2024.06.004_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jtho.2018.12.006","article-title":"EGFR and ERBB2 germline mutations in Chinese lung cancer patients and their roles in genetic susceptibility to cancer","volume":"14","author":"Lu","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2024.06.004_bib16","doi-asserted-by":"crossref","first-page":"S1107","DOI":"10.1016\/j.jtho.2021.08.515","article-title":"P48.04 EGFR germline mutations in Chinese lung cancer patients: a single institutional, retrospective study","volume":"16","author":"Zhou","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.774156","article-title":"Identification of the unique clinical and genetic features of Chinese lung cancer patients with EGFR germline mutations in a large-scale retrospective study","volume":"11","author":"Lin","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib18","doi-asserted-by":"crossref","first-page":"98384","DOI":"10.18632\/oncotarget.21842","article-title":"EGFR mutation, smoking, and gender in advanced lung adenocarcinoma","volume":"8","author":"Tseng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2024.06.004_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lungcan.2015.03.018","article-title":"Risk of malignancy in pulmonary nodules: a validation study of four prediction models","volume":"89","author":"Al-Ameri","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2024.06.004_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/ng1671","article-title":"Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR","volume":"37","author":"Bell","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2024.06.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102603","article-title":"24P EGFR PACC mutations occur more frequently in compound than classical mutations with improved responses to TKIs","volume":"9","author":"Le","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.jtho.2024.06.004_bib22","article-title":"An overview of lung cancer in women and the impact of estrogen in lung carcinogenesis and lung cancer treatment","volume":"8","author":"Rodriguez-Lara","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtho.2024.06.004_bib23","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-07-5030","article-title":"Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms","volume":"14","author":"Bell","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2024.06.004_bib24","article-title":"Characteristics of patients with EGFR -mutant non-small cell lung cancer (NSCLC) at a diverse metropolitan cancer center","volume":"40","author":"Chen","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2024.06.004_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtho.2024.06.004_bib27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1470-2045(15)00026-1","article-title":"Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.annonc.2022.02.225","article-title":"Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)","volume":"33","author":"Janning","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2024.06.004_bib29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-021-03898-1","article-title":"Structure-based classification predicts drug response in EGFR-mutant NSCLC","volume":"597","author":"Robichaux","year":"2021","journal-title":"Nature"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086424006142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086424006142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:46:36Z","timestamp":1759351596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086424006142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1556086424006142"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2024.06.004","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}]}}